3320.HK
3320.HK
HK0000311099
CHINARES PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 269.574.326.000 257.673.256.000
4.6%
Cost of Revenue 225.066.480.000 216.984.387.000
3.7%
Gross Profit 44.507.846.000 40.688.869.000
9.4%
30.456.201.000 27.419.051.000
11.1%
Operating Income 14.051.645.000 13.269.818.000
5.9%
Pretax Income 11.795.812.000 10.929.922.000
7.9%
Net Income Common Stockholders 4.045.468.000 3.350.857.000
20.7%
-- --
--
-- --
--
ende